Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Visit One News Page for Australia news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Australia news headlines.

older | 1 | .... | 1437 | 1438 | (Page 1439) | 1440 | 1441 | .... | 1460 | newer

    0 0

    Asian shares mixed on US partial shutdown, Wall Street slump SINGAPORE (AP) - Asian stocks were mostly lower with light trading on Monday as a Wall Street slump and a partial U.S. government shutdown stemmed holiday cheer. KEEPING SCORE: South Korea's Kospi dropped 0.2 percent to 2,058.19 while the Shanghai Composite index rose 0.1 percent to 2,519.71. Hong Kong's Hang Seng lost 0.7 percent to 25,572.50. Australia's S&P ASX 200 added 0.2 percent to 5,475.90. Stocks fell in Taiwan and... Reported by WorldNews 32 minutes ago.

    0 0

    MELBOURNE (Reuters) - Huddersfield Town midfielder Aaron Mooy has been ruled out Australia's Asian Cup defence after a thorough assessment of his ligament injury, the Football Federation Australia (FFA) said on Monday. Reported by SBS 2 hours ago.

    0 0

    Graham Arnold hits back at Celtic and claims they should be thanking him The Australia boss insists he is doing a favour to the Hoops, and Hibs, by letting players playing the Boxing Day games. Reported by Daily Record 2 hours ago.

    0 0

    Girlfriend of man killed by Domino's driver found dead hours after being told love her life had died The heartbroken girlfriend of a young man killed in a freak accident in Western Australia has been found dead, only hours after learning of her partner's tragic fate. Reported by MailOnline 2 hours ago.

    0 0

    JinkoSolar Wins Most Globalized PV Module Enterprise Award SHANGHAI, Dec. 24, 2018 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or "Company"), (NYSE: JKS), a reputable solar module manufacturer in the world, today announced that it was named most globalized enterprise at South Korea's first Future Enterprise Conference held at the Korea Press Center in Seoul on December 18.

    Industry Award Korea is sponsor of the annual award, which is given to the world's most future-oriented enterprises. In addition to JinkoSolar, Schneider Electric SE, Siemens AG, Hilscher Gesellshaft fur Systemautomation mbH, Mitsubishi Electric Corporation, LG Electronics Inc. and Hyundai Heavy Industries Co. Ltd. won honorable mentions at the conference.

    Gener Miao, Vice President of Sales & Marketing of JinkoSolar was jubilant in receiving the prestigious award. "This affirms JinkoSolar's iconic position in the global PV industry," Mr. Miao said. "We are honored to be recognized among such a gallery of the world's solar companies. Like them, we are dedicated to a future energy economy in which renewable energy plays a leading role."

    Prominent South Korean congressmen attended the ceremony, including Representative Woo Won-shik, a member of the Minjoo Party, and seven other members of the National Assembly.

    *About JinkoSolar Holding Co., Ltd.*

    JinkoSolar (NYSE: JKS) is a world-renowned solar module manufacturer. JinkoSolar has over 12,000 employees across its 6 productions facilities globally. The company distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in more than 80 countries worldwide. JinkoSolar has built a vertically integrated solar product value chain, with an integrated annual capacity of 9.2 GW for silicon ingots and wafers, 6.5 GW for solar cells, and 10 GW for solar modules, as of September 30, 2018.               

    JinkoSolar has over 12,000 employees across its 6 productions facilities globally, 16 oversea subsidiaries in Japan (2), Singapore, India, Turkey, Germany, Italy, Switzerland, United States, Canada, Mexico, Brazil, Chile, Australia, South Africa and United Arab Emirates, and global sales teams in United Kingdom, Bulgaria, Greece, Romania, Jordan, Saudi Arabia, South Africa, Egypt, Morocco, Ghana, Kenya, Costa Rica, Colombia, Panama and Argentina.

    To find out more, please see: www.jinkosolar.com

    *Safe Harbor Statement*

    This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will,""expects,""anticipates,""future,""intends, "plans,""believes,""estimates" and similar statements. Among other things, the quotations from management in this press release and the Company's operations and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in JinkoSolar's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

    *For investor and media inquiries, please contact: *

    In China:
    Mr. Sebastian Liu
    JinkoSolar Holding Co., Ltd.
    Tel: +86 21-5183-3056
    Email: pr@jinkosolar.com

    View original content:http://www.prnewswire.com/news-releases/jinkosolar-wins-most-globalized-pv-module-enterprise-award-300770575.html

    Related Links :

    http://www.jinkosolar.com Reported by PR Newswire Asia 2 hours ago.

    0 0

    Australia have accepted Aaron Mooy will play no part at the Asian Cup, meaning a call up for James Jeggo. Mooy suffered a torn ligament in his right knee during Huddersfield Town’s 1-0 loss to Arsenal on December 8 and was ruled out for eight weeks by the Premier League strugglers. Football Federation Australia (FFA) optimistically named Mooy […]

    The post Mooy officially ruled out as Jeggo gets Australia call appeared first on Soccer News. Reported by SoccerNews.com 20 minutes ago.

    0 0

    [UAE], Dec 24 (ANI): Australia head cricket coach Justin Langer on Monday said all-rounder Mitchell Marsh is "an attractive commodity" for the hosts at the Melbourne Cricket Ground (MCG). Reported by Sify 2 hours ago.

    0 0

    Australia named a seven-year-old boy as their co-captain ahead of the third Test of the Border-Gavaskar Trophy at the Melbourne Cricket Ground (MCG), starting December 26. Reported by Sify 2 hours ago.

    0 0

    Huddersfield midfielder Aaron Mooy ruled out of Australia's Asian Cup defence Huddersfield Town midfielder Aaron Mooy was ruled out Australia's Asian Cup defence after a thorough assessment of his knee ligament injury, the Football Federation has Australia confirmed. Reported by MailOnline 1 hour ago.

    0 0

    JinkoSolar Announces Results of 2018 Annual General Meeting SHANGHAI, Dec. 24, 2018 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE: JKS), a reputable solar module manufacture in the world, today announced that all shareholders resolutions proposed at the Company's 2018 annual general meeting held today were duly passed. Specifically, the shareholders passed the following resolutions approving:

    1. The re-election of Mr. Markscheid Steven as a director of the Company;
    2. The re-election of Mr. Wing Keong Siew as a director of the Company;
    3. The ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2018;
    4. The authorization of the directors of the Company to determine the remuneration of the auditors; and
    5. The authorization of each of the directors of the Company to take any and all action that might be necessary to effect the forgoing resolutions 1 to 4 as such director, in his or her absolute discretion, thinks fit.

    *About JinkoSolar Holding Co., Ltd.*

    JinkoSolar (NYSE: JKS) is one of the world's largest and foremost solar module manufacturers. JinkoSolar distributes its solar products and sells its solutions and services to a diversified international utility, commercial and residential customer base in China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, and other countries and regions. JinkoSolar has built a vertically integrated solar product value chain, with an integrated annual capacity of 9.2 GW for silicon wafers, 6.5 GW for solar cells, and 10.0 GW for solar modules, as of September 30, 2018.

    JinkoSolar has over 12,000 employees across its 6 productions facilities globally, 15 oversea subsidiaries in Japan (2), Singapore, India, Turkey, Germany, Italy, Switzerland, United States, Canada, Mexico, Brazil, Chile, Australia and United Arab Emirates, and global sales teams in United Kingdom, Bulgaria, Greece, Romania, Jordan, Saudi Arabia, Egypt, Morocco, Ghana, Kenya, South Africa, Costa Rica, Colombia, Panama and Argentina.

    To find out more, please see: www.jinkosolar.com.

    *Safe-Harbor Statement*

    This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will,""expects,""anticipates,""future,""intends, "plans,""believes,""estimates" and similar statements. Among other things, the quotations from management in this press release and the Company's operations and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in JinkoSolar's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. Except as required by law, the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

    *For investor and media inquiries, please contact:*

    *In China:
    *Sebastian Liu
    JinkoSolar Holding Co., Ltd.
    Tel: +86 21-5183-3056
    Email: ir@jinkosolar.com

    Christian Arnell
    Christensen
    Tel: +86-10-5900-2940
    Email: carnell@christensenir.com

    *In the U.S.:
    *Ms. Linda Bergkamp
    Christensen
    Tel: +1-480-614-3004
    Email: lbergkamp@ChristensenIR.com

    View original content:http://www.prnewswire.com/news-releases/jinkosolar-announces-results-of-2018-annual-general-meeting-300770576.html

    Related Links :

    http://www.jinkosolar.com Reported by PR Newswire Asia 2 hours ago.

    0 0

    With injuries galore in the Indian side, there could be a chance that the bench strength is tested. Cricket experts and former players have suggested a few changes to ensure the visiting side reclaims the lead and regains bragging rights. Reported by Zee News 1 hour ago.

    0 0

    Mooy missing for Australia as injury ends Asian Cup hopes With the Huddersfield playmaker ruled out, James Jeggo has been handed a place in Socceroos squad for the tournament in the United Arab Emirates Reported by Goal.com 1 hour ago.

    0 0

    NEW YORK and MELBOURNE, Australia, Dec. 24, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) will report on its Phase 3 trials and commercial plans at the upcoming Biotech Showcase 2019 to be held in San Francisco, CA from January 7-9, 2019.

    The presentation is scheduled for Monday, January 7 at 2:00 pm PST/ Tuesday, January 8 at 9:00 am AEDT and will be webcast live via https://event.webcasts.com/starthere.jsp?ei=1226368&tp_key=1f4916da2a

    The presentation will also be available as an archived webcast for 90 days on the Investors & Media section of the Company’s website at www.mesoblast.com

    *About Mesoblast *
    Mesoblast Limited (ASX: MSB; Nasdaq: MESO) is a world leader in developing allogeneic (off-the-shelf) cellular medicines. The Company has leveraged its proprietary technology platform to establish a broad portfolio of late-stage product candidates with three product candidates in Phase 3 trials – acute graft versus host disease, chronic heart failure, and chronic low back pain due to degenerative disc disease. Through a proprietary process, Mesoblast selects rare mesenchymal lineage precursor and stem cells from the bone marrow of healthy adults and creates master cell banks, which can be industrially expanded to produce thousands of doses from each donor that meet stringent release criteria, have lot to lot consistency, and can be used off-the-shelf without the need for tissue matching. Mesoblast has facilities in Melbourne, New York, Singapore and Texas and is listed on the Australian Securities Exchange (MSB) and Nasdaq (MESO). www.mesoblast.com

     
    For further information, please contact:
    Julie Meldrum Schond Greenway
    Corporate Communications Investor Relations
    T: +61 3 9639 6036 T: +1 212 880 2060
    E: julie.meldrum@mesoblast.com E: schond.greenway@mesoblast.com Reported by GlobeNewswire 1 hour ago.

    0 0
  • 12/24/18--04:11: Big Bash League Scoreboard
  • Dec 24 (OPTA) - Scoreboard at close of play of match 8 between Sydney Thunder and Sydney Sixers on Monday at Sydney, Australia Sydney Thunder win by 21 runs Sydney Thunder 1st innings Jos Buttler c Sean Abbott b Steve O'Keefe 63 Shane Watson b Sean Abbott 19 Callum Ferguson Run Out Josh Philippe 23 Joe Root b Steve O'Keefe 9 Jason Sangha c Sean Abbott b Tom Curran 3 Daniel Sams c Josh Ph Reported by Reuters India 30 minutes ago.

    0 0
  • 12/24/18--03:42: Tributes to ex footballer
  • Tributes have been paid to a footballer and talented sportsman killed in a crash in Australia on Saturday. Reported by Express and Star 59 minutes ago.

    0 0

    India announced the squad for ODI series in Australia and New Zealand, apart from the team to play the T20Is in New Zealand Reported by CricBuzz 27 minutes ago.

    0 0

    MediPharm Labs Maintains Largest Cannabis Extraction-Only Footprint in Canada

    TORONTO, Dec. 24, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “*Company*” or “*MediPharm Labs*”) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc. (“*MediPharm*”),  has received approval from Health Canada to increase its current annual production capacity to process up to 150,000KG of dried cannabis, over five extraction lines, up from its standing processing capacity of up to 100,000KG over three extraction lines. The increase reflects the addition of a newly constructed extraction clean room, with new highly specialized and calibrated equipment, including two new extraction lines, that could produce up to 6,500KG of cannabis resin on an annual basis, the equivalent of approximately 9.7 million vape pens. With this expansion, MediPharm maintains its specialized leadership position with the largest extraction-only footprint in Canada, utilizing ISO designed clean rooms and critical environment laboratories, and proprietary methodologies.“We are executing on our vision of global leadership in the extraction of purified cannabis concentrates, adding scale to our first-mover advantage in expertise and leadership,” said Pat McCutcheon, President and CEO of MediPharm Labs. “As we work towards completing our Phase 2 expansion, we are focused on the execution of our differentiated extraction-only business model that prioritizes the production of pharmaceutical-grade cannabis concentrates and isolates qualified for domestic distribution and, more importantly, large global scale distribution.” 

    As MediPharm continues to receive key regulatory approvals to increase its production capacity, the Company is making progress on its Phase 2 expansion plans that will see its annual production extraction capacity increase to upwards of 250,000KG of dried cannabis and is expected to be completed by Q2 2019.  

    Mr. McCutcheon concluded, “As we continue to invest in our growth, the timing couldn’t be better for our two new extraction lines to come onstream with Health Canada’s recent proposed regulations for expanded cannabis products, all of which are concentrate-based. 2019 will be a year focused on extraction in the cannabis industry and we are positioned to service the demand for active ingredient needed to produce beverages, edibles, vapables and topicals, all of which represent the fastest growing segments in the cannabis market.” 

    Pete Patterson, COO & Co-Founder, Vitalis Extraction Technology, commented on MediPharm’s latest production expansion capacity and acquisition of new Vitalis Extraction Equipment, “We are very impressed to see the rate at which MediPharm has been able to scale and execute on their plans. They  are setup to tackle some massive processing contracts that will help the Canadian markets meet the upcoming demand for concentrates.”

    Click on link to download high resolution photos and video of the Extraction Clean Room:  https://www.dropbox.com/sh/agmtfp9228975mk/AAB3woAgATTUH9ScxcvzkF_Ga?dl=0  

    *About Vitalis Extraction Technology *

    Vitalis Extraction Technology Inc.© (Vitalis) is a privately-owned, Kelowna-based engineering and manufacturing company, producing industrial supercritical CO2 extraction systems for the cannabis industry. The company's core focus on innovation and design has vaulted it to the forefront of the market. Renowned for their reliability, scalability, and continuous operation, Vitalis systems are designed and manufactured in its ASME-certified facility in accordance with ASME and CSA Standards for Boiler, Pressure Vessel and Pressure Piping. The vessels are stamped with a CRN and NB registration number confirming that the vessels meet both US and Canadian code requirements. With systems on three continents, Vitalis has the most deployments of industrial CO2 supercritical extractors into the cannabis industry. In 2017 & 2018, Vitalis has won Top Extraction Equipment at the Canadian Cannabis Awards, and several British Columbia-based awards including Manufacturer of the Year and Technology Innovator of the Year. For more information, visit www.vitaliset.com.

    *About MediPharm Labs Corp.*
    Founded in 2015, MediPharm Labs is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access  to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from its cGMP (current Good Manufacturing Practices) and ISO standard-built clean rooms and critical environments laboratory, allows MediPharm Labs to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. MediPharm Labs was awarded *Start-up of the Year* at the recent Canadian Cannabis Awards hosted by Lift & Co.

    Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia. 

    *For further information, please contact: *
    Laura Lepore, Vice President, Investor Relations & Communications

    Telephone: 705-719-7425 ext 216     
    Email: investors@medipharmlabs.com    
    Website:  www.medipharmlabs.com     
           

    *NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.**CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: *

    This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things, expected product offerings and product  equivalents, future capacity expansion, expected GMP certification and the establishment of operations in Australia. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm to obtain adequate financing; and the delay or failure to receive regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.

    A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/f0dce415-9368-4d49-a640-25fc76ad1835

      Reported by GlobeNewswire 21 minutes ago.

    0 0

    The All-India Senior Selection Committee on Monday announced the Indian squad for the upcoming One-Day International (ODI) series against Australia. The same squad has been picked for the ODI series against New Zealand, which begins on January 23. Reported by IndiaTimes 17 minutes ago.

    0 0

    Australia to set up drone-identifying systems The monitoring equipment will be installed at hotspots and restricted areas such as airports. Reported by BBC News 24 minutes ago.

    0 0

    The BCCI on Monday announced the squad for the ODI series against Australia and New Zealand with wicket-keeper batsman Mahendra Singh Dhoni included in the Indian side for the T20I clashes against the Kiwis.  Reported by Zee News 14 minutes ago.

older | 1 | .... | 1437 | 1438 | (Page 1439) | 1440 | 1441 | .... | 1460 | newer